Genscript Biotech (GNNSF, $1.51) was one of the top gainers for the month, rising +2 to $1.51 per share. A.I.dvisor analyzed 848 stocks in the Biotechnology Industry for the month ending February 18, 2025 and discovered that of them (4) exhibited an Uptrend while of them (5) exhibited a Downtrend.